La bourse ferme dans 3 h 36 min

Laboratory Corporation of America Holdings (LH)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
215,67-0,97 (-0,45 %)
À la clôture : 04:00PM EST
215,67 0,00 (0,00 %)
Échanges après Bourse : 06:20PM EST

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein67 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Adam H. SchechterPresident, CEO & Chairman3,72MS.O.1965
Mr. Glenn A. EisenbergCFO & Executive VP1,54M3,43M1961
Mr. Mark S. SchroederExecutive VP, President of Diagnostics Laboratories & COO1,06MS.O.1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVP, President of Early Development Research Laboratories & Chief Medical Officer1,22MS.O.1974
Mr. Peter J. WilkinsonSenior VP & Chief Accounting OfficerS.O.S.O.1972
Mr. Lance V. BerberianExecutive VP and Chief Information & Technology Officer876,62kS.O.1963
Dr. Marcia T. Eisenberg Ph.D.Chief Scientific Officer & Senior VPS.O.S.O.1959
Christin O'DonnellVice President of Investor RelationsS.O.S.O.S.O.
Ms. Sandra D. van der VaartExecutive VP, Chief Legal Officer, Chief Compliance Officer & Corporate SecretaryS.O.S.O.1960
Ms. Amy B. SummyExecutive VP & Chief Marketing OfficerS.O.S.O.1967
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Laboratory Corporation of America Holdings en date du 1 février 2024 est 2. Les scores principaux sont Audit : 5; Société : 7; Droits des actionnaires : 1; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.